STAT

AUGUST 7, 2023

A behind-the-scenes feud over a drug development program erupted into public view as Nektar Therapeutics filed a lawsuit accusing Eli Lilly of undermining a project in favor of another deal. But the arrangement went awry after Lilly spent about $1.1

Drug Development 245

Drug Development Drug Pricing 245

STAT

OCTOBER 18, 2023

… Investors in biopharma companies, who lobbied vigorously — but unsuccessfully — against allowing Medicare to negotiate drug prices, are trying a new tactic to preserve their profits , The Boston Globe tells us.  Between 2017 and 2021, annual new HIV infections fell by 12%.

Drug Pricing 281

Drug Pricing 281

pharmaphorum

NOVEMBER 30, 2020

The platform uses AI to “dramatically free up the time spent on crunching datasets, modelling scenarios and building price predictions,” says Okra, a Cambridge-based company led by Dr Loubna Bouarfa , a machine learning scientist who was formerly a member of the European Commission’s high-level group on AI. Dr Loubna Bouarfa.

Drug Pricing 64

Drug Pricing Communication 64

HealthPartners

MAY 5, 2021

Understanding pharmacy benefit management and drug pricing The U.S. prescription drug supply chain is extraordinarily complex. It captures, with strong simplification, the web of stakeholders in the prescription drug market and the myriad of contractual agreements that drives the cash flows between them.

Drug Pricing 40

Drug Pricing Mail-Order Pharmacies Pharmaceutical Manufacturing Pharmaceutical Companies 40

Pharmaceutical Technology

NOVEMBER 21, 2022

According to the report, five member companies decided to decrease their investment in Japan between 2016 and 2017, four companies changed their investment targets between 2018 and 2020, and one company lowered the priority given to Japan after 2021. The MHLW is currently proposing discussions on the FY2023 drug price revision.

Drug Pricing 69

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 69

Putting Patients First Blog

SEPTEMBER 3, 2024

Overall, while the NHC appreciates CMS’ intent to streamline the data submission process and make it more accessible, we encourage ongoing dialogue and adjustments to ensure that the process remains patient-centered, efficient, and capable of capturing the full spectrum of information necessary to inform meaningful drug price negotiations.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling Communication 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

However, the FDA's approval of Lumakras for metastatic non-small cell lung cancer in May last year has a global analyst consensus sales forecast of $336m for this year, according to GlobalData’s Drugs Database. BioNTech (18,644.5%) and Moderna (1,842.3%) had more than 100% YoY operating income growth last year due to Covid-19 vaccine demand.

Vaccines 108

Vaccines Drug Pricing Biosimilars Documentation 108

Putting Patients First Blog

SEPTEMBER 7, 2023

Cardiac screening The use of echocardiogram and cardiac MRI in Duchenne increased across most age groups when comparing the time periods 2007-2012, 2013-2017, and 2018-2022 with some age groups having statistical significance. The average age at loss of ambulation for registrants who never used corticosteroids was 10.5

Drug Pricing 111

Drug Pricing 111

Pharmaceutical Technology

MARCH 10, 2023

Consequentially, the five-year average price trend in Lebanon for all medicines has increased to 1,123%. GlobalData reviews the key events leading up to these current price trends in Lebanon. As this reduction of subsidies coincided with the weakening of the Lebanese pound, it resulted in further heavy price increases.

Drug Pricing 52

Drug Pricing Packaging 52

pharmaphorum

MAY 19, 2022

Shkreli had been dubbed “the most hated man in America” for his arrogant and defiant posturing whilst acting as chief executive of Turing Pharma, which hiked the price of off-patent HIV drug Daraprim (pyrimethamine) from $13.50 to $750 per tablet – leaving some patients forced to pay up to $16,000 in out-of-pocket co-pays.

Drug Pricing 21

Drug Pricing 21

Pharmaceutical Technology

NOVEMBER 21, 2022

According to the report, five member companies decided to decrease their investment in Japan between 2016 and 2017, four companies changed their investment targets between 2018 and 2020, and one company lowered the priority given to Japan after 2021. The MHLW is currently proposing discussions on the FY2023 drug price revision.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

Putting Patients First Blog

JULY 2, 2024

General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). This includes collecting data on utilization management practices, formulary changes, and patient experiences.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

Drug Channels

JULY 20, 2021

The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. As you will see below, mail and specialty pharmacies’ purchases of products that are eligible for 340B discounts have grown by an incredible 56% per year since 2017.

Specialty Pharmacies 40

Specialty Pharmacies Drug Pricing Hospitals 40

Safe Biologics

JANUARY 1, 2023

drug distribution system Explain the effects of competition on drug pricing under provider-administered and patient-administered drugs. Upon completion, students will be able to: Discuss the role of pharmaceutical benefit managers (PBMs) in the U.S. 28% were somewhat comfortable, and only 6% were completely comfortable.

Biosimilars 100

Biosimilars Drug Pricing 100

Proxsys Rx

MAY 18, 2023

The skyrocketing costs of prescription drugs It’s no secret that prescription drug prices are rising faster than the rate of inflation, forcing employers to shift more of their prescription benefit costs to their employees and families. Between 2017 and 2022, savings card transactions increased 63%.

Drug Pricing 52

Drug Pricing Dosage Diabetes 52

pharmaphorum

JULY 15, 2022

Teva has asked the Supreme Court to look at a judgment in a $235 million patent dispute with GSK that it claims could undermine the ability of generic drugmakers to bring new products to market, and thereby help reduce drug prices.

Labelling 52

Labelling Drug Pricing 52

pharmaphorum

JANUARY 28, 2021

These bills – which include the Prescription Drug Pricing Reduction Act (PDPRA), HR 6179 and S 3466 – could be the key to finally giving providers what they should have as medical professionals: the freedom to do what’s best for their patients, including prescribing biosimilars when appropriate. About the author.

Biosimilars 119

Biosimilars Insurance Coverage and Processing Drug Pricing Diabetes 119

pharmaphorum

FEBRUARY 18, 2021

Drug prices to plummet in wave of expiring patents”. Price decay after loss of brand exclusivity”. These are just three headlines that come up when you Google “drug patent expiry”. In late 2017, the FDA approved Admelog, Sanofi’s biosimilar of Humalog. “Patent losses could sink Allergan”.

Prescription Filling 52

Prescription Filling Drug Pricing Biosimilars Compounding 52

European Pharmaceutical Review

AUGUST 24, 2023

billion round in 2017 and higher than the next 15 top venture funding rounds of 2022 combined. First, macroeconomic factors like deglobalisation and inflation have increased the cost of capital, creating a need for more streamlined operations. This represented the largest ever venture round in the history of the industry. The figure is 2.5

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 98

pharmaphorum

SEPTEMBER 8, 2020

6 Forbes, ‘Biologic Medicines: The Biggest Driver of Rising Drug Prices’. 2017;(13):47-64. Available from: [link] [Last accessed: September 2020]. 5 Bloomberg, ‘These Are the Economies With the Most (and Least) Efficient Health Care’. Published 17 September 2018. Last accessed: 30 September 2020]. Published 8 March 2019.

Biosimilars 99

Biosimilars Drug Pricing Chemotherapy Vaccines 99

Safe Biologics

FEBRUARY 1, 2024

Over the years, the WHO has attempted to evaluate the BQ: a provisional implementation of the programme was suggested in 2016, and in 2017 a pilot BQ project was discussed. Other supporting agencies await the WHO implementing a global system. In 2018, the project was put on hold for data gathering.

Biosimilars 130

Biosimilars Documentation Drug Pricing 130

European Pharmaceutical Review

JUNE 24, 2022

The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. It is too early to say because we have not seen the whole package of measures yet.

Compounding 105

Compounding Drug Development Drug Pricing Dosage 105

Putting Patients First Blog

JANUARY 27, 2025

11, December 2017, [link] www.cms.gov/About-CMS/Agency-Information/OMH/Downloads/Data-Highlight- Vol11-Dec-2017.pdf. Issue Brief: Improving Prescription Drug Price and Cost Transparency. link] www.ama-assn.org/system/files/issue- brief-improving-drug-price-cost-transparency.pdf. 29 Julia C. 2024.30.2.206.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

Pharmaceutical Technology

JANUARY 6, 2023

In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”.

Documentation 97

Documentation Hospitals Dosage Drug Pricing 97

Safe Biologics

MARCH 10, 2025

This expansion continues a flawed policy that threatens innovation and jeopardizes patient access to critical treatments, including drugs vital for cancer treatment and popular new weight loss medications that have transformed the management of obesity and related conditions. What Will 2025 Mean for Medicare Drug Price Setting Under the IRA?

Biosimilars 130

Biosimilars Independent Pharmacies Drug Pricing Vaccines 130

STAT

FEBRUARY 25, 2025

” During Trump’s first term, his administration embraced the federal authority to mandate hospitals and health insurance companies to disclose prices they had long kept confidential. Continue to STAT+ to read the full story…

Health Insurance Companies 297

Health Insurance Companies Hospitals Drug Pricing 297